Apigenin Market, By Source (Natural and Synthetic), By Form, By Application, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Apigenin Market size was valued at US$ 3,720.32 Million in 2024, expanding at a CAGR of 4.50% from 2025 to 2032.
Apigenin is a naturally occurring flavonoid abundantly found in fruits, vegetables, and herbs, with particularly high concentrations in parsley, celery, and chamomile. Recognized for its antioxidant, anti-inflammatory, and anti-cancer properties, apigenin belongs to the flavone class and plays a significant role in the health and wellness industries due to its broad therapeutic benefits and minimal side effects compared to synthetic drugs. The growing demand for apigenin is fueled by its extensive health-promoting properties. As a potent antioxidant, it helps neutralize free radicals, reducing oxidative stress, a major contributor to aging and chronic diseases. Its anti-inflammatory effects make it particularly beneficial in managing conditions such as arthritis and cardiovascular disorders.
Apigenin is also gaining attention in oncology, where research indicates its ability to induce apoptosis (programmed cell death) and inhibit tumor growth in various cancers, including breast, prostate, and colon cancer. Additionally, its neuroprotective benefits support brain health by promoting neuron formation and potentially lowering the risk of neurodegenerative diseases such as Alzheimer’s. Beyond healthcare, apigenin is widely utilized in the cosmetics industry for its skin-soothing and anti-aging properties, making it a valuable ingredient in skin rejuvenation products. Its inclusion in dietary supplements aligns with the increasing consumer demand for natural health-enhancing compounds, solidifying its importance across multiple sectors, including pharmaceuticals and nutraceuticals.
Apigenin Market- Market Dynamics
- Growing Demand for Natural Antioxidants and Anti-Cancer Compounds in Pharmaceuticals and Nutraceuticals
As consumer health awareness increases, there is a rising preference for plant-based and naturally derived compounds over synthetic alternatives, primarily due to their reduced side effects and holistic health benefits. Apigenin, known for its powerful antioxidant properties, helps combat oxidative stress, a key contributor to chronic conditions such as cardiovascular disease, neurodegenerative disorders, and aging-related issues. Additionally, its anti-cancer effects, including its ability to induce apoptosis and inhibit tumor cell proliferation, make it highly sought after in cancer prevention and treatment research. In the nutraceutical industry, apigenin is increasingly incorporated into dietary supplements aimed at boosting immune support, offering anti-inflammatory benefits, and promoting general wellness. This reflects the growing demand for preventive healthcare solutions that prioritize natural, effective ingredients.
According to a report from the Indian Ministry of AYUSH, the global market for plant-based health products, including natural antioxidants, is experiencing significant growth, driven by government-backed initiatives promoting traditional and herbal medicines. This shift aligns with broader health trends favoring natural compounds over synthetic ingredients, underscoring apigenin’s crucial role in shaping the future of both pharmaceuticals and nutraceuticals. As sustainable sourcing practices and technological advancements continue, apigenin’s market potential is poised to expand further.
Apigenin Market- Segmentation Analysis:
The Global Apigenin Market is segmented on the basis of Source, Form, Application, and Region.
The market is segmented into two categories based on Source: Natural and Synthetic. Natural sources dominate the market due to the increasing consumer preference for plant-based, eco-friendly products with minimal side effects and proven health benefits. Additionally, regulatory support for organic ingredients has further boosted the demand for naturally sourced compounds like apigenin. In terms of Application, the market is divided into four key segments: Pharmaceuticals, Food & Beverages, Cosmetics & Personal Care, and Dietary Supplements. Food & Beverages holds the largest market share due to its widespread use as a natural antioxidant and preservative, which enhances product shelf life and nutritional value. The growing demand for functional foods and beverages enriched with health-promoting bioactive compounds continues to drive the dominance of this segment.
According to a report by The Business Research Company, the natural antioxidants market is projected to grow from $2.73 billion in 2024 to $2.98 billion in 2025, at a compound annual growth rate (CAGR) of 9.1%. This growth is attributed to increased consumer awareness, rising prevalence of chronic diseases, and growing demand for natural and organic food products. In the United States, the Organic Trade Association reported that the organic food and beverage sector reached $61.7 billion in sales in 2022, highlighting the significant consumer demand for organic products. Furthermore, the U.S. Department of Agriculture (USDA) has implemented regulations to ensure the authenticity of organic products, including the requirement for all organic imports to be declared as USDA organic foods and contain an associated National Organic Program (NOP) import certificate.
Apigenin Market- Geographical Insights
In North America, particularly in the United States, there is a growing consumer preference for natural and plant-based ingredients in pharmaceuticals, nutraceuticals, and functional foods, positioning it as one of the leading markets for apigenin. This demand is fueled by increasing awareness of the health benefits of antioxidants and anti-cancer compounds. The market\'s growth is further supported by a strong regulatory framework and ongoing advancements in research.
In Europe, the apigenin market is expanding due to the rising popularity of organic and natural products in food, beverages, and personal care. The European Union\'s stringent regulations on synthetic chemicals in food and cosmetics have accelerated the adoption of plant-derived ingredients like apigenin, driving further market growth. The Asia-Pacific region, particularly in India and China, is experiencing rapid growth in the apigenin market. This growth is largely driven by a shift toward traditional herbal remedies and natural products in health supplements and food. Government initiatives that promote the use of herbal and natural ingredients in healthcare are also contributing to the expansion of the apigenin market in this region.
Apigenin Market- Competitive Landscape:
The Apigenin market is marked by intense competition, with numerous players focusing on capitalizing on the rising demand for natural antioxidants and health-promoting compounds. Key market participants employ various strategies, including product innovation, partnerships, and collaborations, to solidify their market presence. Companies are heavily investing in research and development to enhance the bioavailability and effectiveness of apigenin, expanding its use across pharmaceuticals, nutraceuticals, and cosmetics. The growing preference for plant-based and organic ingredients has intensified competition among suppliers to source high-quality apigenin from natural and sustainable sources.
In terms of market share, the pharmaceutical and nutraceutical sectors are highly competitive, with businesses striving to secure regulatory approvals and develop formulations that appeal to health-conscious consumers. The food and beverages sector is also witnessing rising competition, as manufacturers incorporate apigenin into functional foods and beverages to meet the increasing demand for antioxidant-rich products. Additionally, the cosmetics industry is increasingly utilizing apigenin for its anti-aging and skin-soothing properties, adding further competition in the beauty and personal care market. Given the global nature of the market, companies are expanding their presence internationally, targeting emerging regional markets such as Asia-Pacific and Latin America, where there is growing consumer demand for natural health solutions.
Recent Developments:
- May 2024: Tally Health launched its Restore Sleep and Longevity Formula, a blend of botanicals and nutraceuticals designed to promote relaxation and address age-related health issues.
- April 2024: 4Life introduced Transfer Factor AgePro, a new product combining apigenin with other powerful compounds to enhance immune support and promote longevity. This product reflects 4Life\'s commitment to scientifically backed formulations and exclusive plant extracts aimed at improving health and wellness.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL APIGENIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Monteloeder S.L.
Sigma-Aldrich Corporation
Aksuvital Gda Sanayi ve Ticaret A..
Bo International Pvt. Ltd.
Indo Phytochem Pharmaceuticals Pvt. Ltd.
Shaanxi QingLan Bio-Technology Co., Ltd.
Xi\'an Incedit Bio-Tech Co., Ltd.
Xi\'an Sost Biotech Co., Ltd.
Shaanxi Pioneer Biotech Co., Ltd.
Xi\'an Lyphar Biotech Co., Ltd.
Others
GLOBAL APIGENIN MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032
Natural
Synthetic
GLOBAL APIGENIN MARKET, BY FORM - MARKET ANALYSIS, 2019 - 2032
Powder
Liquid
GLOBAL APIGENIN MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Pharmaceuticals
Food & Beverages
Cosmetics & Personal Care
Dietary Supplements
Others
GLOBAL APIGENIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- Uk
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest Of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest Of Apac
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest Of Latam
The Middle East And Africa
- Saudi Arabia
- Uae
- Israel
- Turkey
- Algeria
- Egypt
- Rest Of Mea
TABLE OF CONTENT
1. Apigenin Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Apigenin Market Snippet by Source
2.1.2. Apigenin Market Snippet by Form
2.1.3. Apigenin Market Snippet by Application
2.1.4. Apigenin Market Snippet by Country
2.1.5. Apigenin Market Snippet by Region
2.2. Competitive Insights
3. Apigenin Key Market Trends
3.1. Apigenin Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Apigenin Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Apigenin Market Opportunities
3.4. Apigenin Market Future Trends
4. Apigenin Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Apigenin Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Apigenin Market Landscape
6.1. Apigenin Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Apigenin Market – By Source
7.1. Overview
7.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
7.1.2. Natural
7.1.3. Synthetic
8. Apigenin Market – By Form
8.1. Overview
8.1.1. Segment Share Analysis, By Form, 2024 & 2032 (%)
8.1.2. Powder
8.1.3. Liquid
9. Apigenin Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Pharmaceuticals
9.1.3. Food & Beverages
9.1.4. Cosmetics & Personal Care
9.1.5. Dietary Supplements
9.1.6. Others
10. Apigenin Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Apigenin Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Apigenin Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Apigenin Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Apigenin Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Apigenin Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Apigenin Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Monteloeder S.L.
11.2.2. Sigma-Aldrich Corporation
11.2.3. Aksuvital Gda Sanayi ve Ticaret A..
11.2.4. Bo International Pvt. Ltd.
11.2.5. Indo Phytochem Pharmaceuticals Pvt. Ltd.
11.2.6. Shaanxi QingLan Bio-Technology Co., Ltd.
11.2.7. Xi\'an Incedit Bio-Tech Co., Ltd.
11.2.8. Xi\'an Sost Biotech Co., Ltd.
11.2.9. Shaanxi Pioneer Biotech Co., Ltd.
11.2.10. Xi\'an Lyphar Biotech Co., Ltd.
11.2.11. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
